These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3003728)

  • 1. [Treatment of cardiac failure with enalapril].
    Bounhoure JP
    Presse Med; 1985 Dec; 14(44):2215-7. PubMed ID: 3003728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state.
    Cleland JG; Dargie HJ; Ball SG; Gillen G; Hodsman GP; Morton JJ; East BW; Robertson I; Ford I; Robertson JI
    Br Heart J; 1985 Sep; 54(3):305-12. PubMed ID: 2994698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin-Angiotensin-Aldosterone Signaling Inhibitors-Losartan, Enalapril, and Cardosten-Prevent Infarction-induced Heart Failure Development in Rats.
    Kiss K; Fekete V; Pálóczi J; Sárközy M; Murlasits Z; Pipis J; Kheyfets IA; Dugina JL; Sergeeva SA; Epstein OI; Csonka C; Csont T; Ferdinandy P; Bencsik P
    Altern Ther Health Med; 2016; 22(2):10-7. PubMed ID: 27036051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin converting enzyme inhibitors in congestive heart failure. Overview in comparison of captopril and enalapril.
    Levine TB; Olivari MT; Cohn JN
    Am J Med; 1986 Oct; 81(4C):36-9. PubMed ID: 3022583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of angiotensin-converting enzyme inhibitors in congestive heart failure.
    Galvao M
    Heart Lung; 1990 Sep; 19(5 Pt 1):505-11. PubMed ID: 2211159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure.
    Hall D; Zeitler H; Rudolph W
    J Am Coll Cardiol; 1992 Dec; 20(7):1549-55. PubMed ID: 1452929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
    Sigurdsson A
    Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
    Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enalapril in chronic heart failure, a double-blind placebo-controlled study.
    Remes J; Nikander P; Rehnberg S; Halinen MO; Kuikka J; Länsimies E; Pyörälä K
    Ann Clin Res; 1986; 18(3):124-8. PubMed ID: 3017174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of enalapril on clinical status, biochemistry, exercise performance and haemodynamics in heart failure.
    Webster MW; Fitzpatrick MA; Hamilton EJ; Nicholls MG; Ikram H; Espiner EA; Wells JE
    Drugs; 1985; 30 Suppl 1():74-81. PubMed ID: 2994990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (ATMOSPHERE) study.
    Krum H; Massie B; Abraham WT; Dickstein K; Kober L; McMurray JJ; Desai A; Gimpelewicz C; Kandra A; Reimund B; Rattunde H; Armbrecht J;
    Eur J Heart Fail; 2011 Jan; 13(1):107-14. PubMed ID: 21169387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of chronic angiotensin II type I receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic variables in patients with heart failure.
    Davie AP; Rumley A; Lowe GD; McMurray JJ
    Thromb Haemost; 2001 Dec; 86(6):1585-6. PubMed ID: 11776334
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.
    Jorde UP; Vittorio TJ; Dimayuga CA; Homma S; Rizkala A; Le Jemtel TH; Katz SD
    Am J Cardiol; 2004 Dec; 94(12):1501-5. PubMed ID: 15589004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acetylsalicylic acid antagonism vs ACE inhibitor in congestive heart failure as shown by a diminished respiratory and exercise capacity].
    Guazzi M; Lauri G; Melzi G; Cattadori G; Agostoni P
    Cardiologia; 1996 Jun; 41(6):527-33. PubMed ID: 8766415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effects of digitalis and enalapril on the neurohormonal profile of chagasic patients with severe congestive heart failure.
    Khoury AM; Davila DF; Bellabarba G; Donis JH; Torres A; Lemorvan C; Hernandez L; Bishop W
    Int J Cardiol; 1996 Nov; 57(1):21-9. PubMed ID: 8960939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of frusemide and angiotensin-converting enzyme inhibitors and their combination on cardiac and renal haemodynamics in heart failure.
    Cleland JG; Gillen G; Dargie HJ
    Eur Heart J; 1988 Feb; 9(2):132-41. PubMed ID: 2832173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enalapril reduces QTc dispersion in mild congestive heart failure secondary to coronary artery disease.
    Barr CS; Naas AA; Fenwick M; Struthers AD
    Am J Cardiol; 1997 Feb; 79(3):328-33. PubMed ID: 9036753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical pharmacology of enalapril.
    Gomez HJ; Cirillo VJ; Jones KH
    J Hypertens Suppl; 1983 Oct; 1(1):65-70. PubMed ID: 6100610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study.
    Packer M; Gheorghiade M; Young JB; Costantini PJ; Adams KF; Cody RJ; Smith LK; Van Voorhees L; Gourley LA; Jolly MK
    N Engl J Med; 1993 Jul; 329(1):1-7. PubMed ID: 8505940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both.
    Yan RT; White M; Yan AT; Yusuf S; Rouleau JL; Maggioni AP; Hall C; Latini R; Afzal R; Floras J; Masson S; McKelvie RS;
    Am J Cardiol; 2005 Sep; 96(5):698-704. PubMed ID: 16125499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.